The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
SUNNYVALE, Calif., Oct. 15, 2024 /PRNewswire/ -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming the diagnosis and management of ...
CeriBell (NASDAQ:CBLL) executives said the company's first-quarter results reflected continued momentum in both new account additions and increased usage among existing hospital customers, while ...
Add Yahoo as a preferred source to see more of our stories on Google. Research indicates that around 800 Ceribell has obtained a breakthrough device designation for its large vein occlusion (LVO) ...
CeriBell offering 10.6 mln shares vs 6.7 mln earlier Lifts IPO price range to $16-$17 each from $14-$16 Some existing investors may buy shares worth up to $40 mln Oct 9 (Reuters) - TPG-backed CeriBell ...
(RTTNews) - CeriBell, Inc. (CBLL) announces that the U.S. FDA has granted 510(k) clearance for its next-generation Clarity algorithm to detect electrographic seizures in preterm neonates through ...
Led by Ally Bridge Group and with the help of its existing shareholders, venture-backed Ceribell, Inc. has raised $50 million. The funding was structured as an extension of its $53 million Series C ...
SUNNYVALE, Calif., June 08, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with ...
SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with ...
Recent strong debuts by weight-loss drug developer BioAge Labs and TPG-backed cancer therapy developer Bicara Therapeutics, among others, have also bolstered investor confidence in the sector and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results